Contineum Therapeutics, Inc, based in San Diego, CA, is a cutting-edge biotechnology company focused on developing precision small molecules to address clinical impairment in the field of neuroscience. Their innovative approach targets inflammation and immunology to potentially alter the course of neurological conditions.
With a dedicated team of board members, scientists, and staff, Contineum Therapeutics is committed to advancing research and creating impactful therapies that aim to reconnect patients with a better quality of life. Through their strategic programs and publications, the company is at the forefront of pioneering treatments for neurological disorders.
Generated from the website